Defining the Intensity of Conditioning Regimens: Working Definitions
Top Cited Papers
Open Access
- 2 September 2009
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 15 (12), 1628-1633
- https://doi.org/10.1016/j.bbmt.2009.07.004
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2009
- Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantationBlood, 2006
- Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and MyelodysplasiaJournal of Clinical Oncology, 2005
- Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMTBlood, 2005
- Low Dose Total Body Irradiation Followed by Allogeneic Lymphocyte Infusion for Refractory Hematologic Malignancy—an Updated ReviewLeukemia & Lymphoma, 2004
- Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaBlood, 2003
- Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity surveyBone Marrow Transplantation, 2002
- One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and β-thalassaemia major: potential cure of both marrow disordersBone Marrow Transplantation, 2000
- Marrow Transplantation for Thalassemia after Treatment with Busulfan and CyclophosphamideaAnnals of the New York Academy of Sciences, 1985
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983